| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |